Tecentriq Patient Website

Brand: Tecentriq (atezolizumab), Intravenous Infusion
Parent Company: Genentech
Drug Type: Prescription
Drug Category: Oncology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.tecentriq.com/patient.html
HCP Website: https://www.tecentriq.com/hcp.html